Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospit. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Yatharth Hospital & Trauma Care Services Ltd

₹ 799 1.91%
17 Sep 11:30 a.m.
yatharthhospitals.com BSE: 543950 NSE: YATHARTH
About

Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]

Key Points

Hospital Portfolio: [1]
- Total Hospitals: 7 hospitals across North India with 87% of the beds in Metro.

Locations and Beds:[2]
- Greater Noida: 400 beds (112 ICU beds, 66% occupancy).
- Noida: 250 beds (81 ICU beds, 83% occupancy).
- Noida Extension: 450 beds (125 ICU beds, 60% occupancy).
- Jhansi-Orchha: 305 beds (76 ICU beds, 47% occupancy).
- Greater Faridabad: 200 beds (61 ICU beds, ramping up at 28% occupancy).

  • Upcoming Hospitals[3]
    • Model Town, Delhi: ~300 beds.
    • Faridabad (new hospital): ~400 beds.
Website BSE NSE
  • Market Cap ₹ 7,694 Cr.
  • Current Price ₹ 799
  • High / Low ₹ 820 / 345
  • Stock P/E 84.0
  • Book Value ₹ 158
  • Dividend Yield 0.00 %
  • ROCE 10.1 %
  • ROE 7.42 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 156% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 12.9% over last 3 years.
  • Working capital days have increased from 351 days to 596 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
83 94 97 97 102 110 102 106 119 113 110 112 130
60 67 69 69 73 79 72 78 86 82 79 80 95
Operating Profit 23 27 28 28 29 31 29 28 33 31 32 32 35
OPM % 28% 28% 29% 29% 28% 28% 29% 26% 28% 27% 29% 28% 27%
0 0 1 0 0 3 5 5 3 2 3 4 7
Interest 2 2 3 2 2 2 0 0 0 0 0 0 0
Depreciation 3 3 3 4 3 3 4 3 4 5 5 5 5
Profit before tax 19 23 22 22 24 30 30 29 31 27 30 31 37
Tax % 29% 30% 12% 30% 35% 30% 30% 10% 26% 26% 25% 29% 28%
13 16 20 15 16 21 21 26 23 20 22 22 27
EPS in Rs 2.02 2.43 3.00 2.34 2.38 2.45 2.46 3.06 2.70 2.38 2.31 2.27 2.81
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
71 78 91 123 165 278 331 394 454 465
53 59 72 92 120 193 225 275 327 336
Operating Profit 18 18 20 31 45 85 106 119 127 129
OPM % 25% 24% 22% 25% 27% 31% 32% 30% 28% 28%
0 0 0 0 1 1 2 14 12 16
Interest 6 5 6 14 13 13 10 6 1 1
Depreciation 7 6 8 15 14 13 13 13 19 19
Profit before tax 5 8 6 3 18 60 86 113 119 126
Tax % 41% 23% 51% 72% 31% 30% 25% 26% 27%
3 6 3 1 12 42 64 84 88 92
EPS in Rs 2.22 3.76 1.78 0.49 7.53 6.42 9.79 9.78 9.10 9.77
Dividend Payout % -0% -0% -0% -0% -0% -0% -0% -0% -0%
Compounded Sales Growth
10 Years: %
5 Years: 30%
3 Years: 18%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: 156%
3 Years: 28%
TTM: 0%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 44%
Return on Equity
10 Years: %
5 Years: 15%
3 Years: 13%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 14 16 16 16 16 66 66 86 96
Reserves 24 32 39 40 53 46 111 751 1,429
85 107 120 113 103 115 117 5 7
10 11 22 32 39 59 33 36 42
Total Liabilities 133 166 197 202 211 286 326 878 1,575
51 47 146 134 132 122 121 133 161
CWIP 54 80 -0 -0 -0 -0 -0 -0 153
Investments 7 19 28 33 34 47 47 67 234
20 20 22 34 45 117 159 679 1,026
Total Assets 133 166 197 202 211 286 326 878 1,575

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
25 19 21 24 26 27 26 16 89
-45 -39 -36 -8 -4 -18 -9 -167 -298
21 21 11 -20 -23 -7 -6 241 347
Net Cash Flow 1 2 -4 -4 -1 1 11 89 138

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 58 44 51 54 70 100 95 133 137
Inventory Days 47 42 44 37 33 39
Days Payable 127 106 224 161 154 44
Cash Conversion Cycle -22 -20 -129 -70 -51 100 95 133 131
Working Capital Days 20 7 -15 -7 7 26 85 373 596
ROCE % 9% 7% 10% 18% 37% 37% 21% 10%

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
66.33% 66.44% 66.54% 66.54% 66.54% 61.44% 61.64% 61.64%
5.42% 2.59% 3.99% 4.90% 6.28% 9.78% 4.45% 4.34%
8.88% 8.81% 9.30% 9.40% 6.97% 11.50% 13.56% 13.52%
19.37% 22.15% 20.15% 19.16% 20.20% 17.27% 20.35% 20.50%
No. of Shareholders 50,11351,74346,56751,91662,61673,25185,66881,440

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls